Boris Afanasyev

Boris Afanasyev

UNVERIFIED PROFILE

Are you Boris Afanasyev?   Register this Author

Register author
Boris Afanasyev

Boris Afanasyev

Publications by authors named "Boris Afanasyev"

Are you Boris Afanasyev?   Register this Author

51Publications

2209Reads

29Profile Views

Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.

Leuk Lymphoma 2019 Sep 4;60(9):2316-2319. Epub 2019 Feb 4.

Raisa Gorbacheva Memorial Institute of Children Oncology Hematology and Transplantation, First Saint Petersburg State Pavlov Medical University , Saint Petersburg , Russian Federation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573368DOI Listing
September 2019

Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation.

Hematol Oncol Stem Cell Ther 2019 Sep 6;12(3):140-145. Epub 2019 Apr 6.

Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, Department of Hematology, Transfusiology, Transplantation, Faculty of Postgraduate Education, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S16583876193002
Publisher Site
http://dx.doi.org/10.1016/j.hemonc.2019.03.001DOI Listing
September 2019

Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers.

ACS Appl Mater Interfaces 2019 Apr 27;11(14):13091-13104. Epub 2019 Mar 27.

First I.P. Pavlov State Medical University of St. Petersburg , Lev Tolstoy Street, 6/8 , 197022 Saint Petersburg , Russia.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acsami.8b22685
Publisher Site
http://dx.doi.org/10.1021/acsami.8b22685DOI Listing
April 2019

Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis.

Oncol Res Treat 2017 21;40(10):574-578. Epub 2017 Sep 21.

R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, State Medical University named I.P. Pavlov, Saint-Petersburg, Russian Federation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000477253DOI Listing
October 2018

Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study.

Biol Blood Marrow Transplant 2018 08 13;24(8):1629-1642. Epub 2018 Mar 13.

Department for Children and Adolescents; Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.03.002DOI Listing
August 2018

Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.

Eur J Haematol 2018 May 1;100(5):395-402. Epub 2018 Mar 1.

R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russian Federation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13030DOI Listing
May 2018

Efficient gene editing via non-viral delivery of CRISPR-Cas9 system using polymeric and hybrid microcarriers.

Nanomedicine 2018 01 14;14(1):97-108. Epub 2017 Sep 14.

School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2017.09.001DOI Listing
January 2018

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

J Clin Oncol 2017 Oct 28;35(30):3425-3432. Epub 2017 Aug 28.

Carmen Martínez, Institute of Hematology and Oncology, Hospital Clínic; Carmen Canals, Banc de Sang i Teixits; Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona; Jorge Gayoso, Hospital General Universitario Gregorio Marañón, Madrid; Arancha Bermúdez, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Carmen Martínez, Hervé Finel, Silvia Montoto, Peter Dreger, and Anna Sureda, European Society for Blood and Marrow Transplantation, Paris; Didier Blaise, Institut Paoli Calmettes, Marseille; Edouard Forcade, University Hospital of Bordeaux, Bordeaux; Ibrahim Yakoub-Agha, Centre Hospitalier Regional Universitaire de Lille, Lille Inflammation Research International Center, Institut National de la Santé et de la Recherche Médicale U995, Lille, France; Karl Peggs, University College London Cancer Institute; Michael Potter, The Royal Marsden Hospital; Silvia Montoto, St Bartholomew's Hospital, Barts Health National Health Service Trust, London; Stephen Robinson, Bristol Haematology and Oncology Centre, Bristol; Grant McQuaker, Gartnaval General Hospital, Glasgow; Adrian Bloor, Christie National Health Service Trust Hospital, Manchester, United Kingdom; Alida Dominietto, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Azienda Ospedaliera-Universitaria San Martino-IST, Genova; Luca Castagna, Istituto Clinico Humanitas; Paolo Corradini, Istituto Nazionale dei Tumori, Milan; Domenico Russo, University of Brescia, Brescia, Italy; Boris Afanasyev, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia; Maija Itälä-Remes, Turku University Hospital, Turku, Finland; Christof Scheid, University of Cologne, Cologne; and Peter Dreger, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6869DOI Listing
October 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

J Clin Oncol 2017 Jul 2;35(19):2157-2164. Epub 2017 May 2.

Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Hamburg; Georg-Nikolaus Franke, University Hospital Leipzig, Leipzig; Uwe Platzbecker, University Hospital Dresden, Dresden; Kai Hübel and Christof Scheid, University of Cologne, Cologne; Thomas Weber, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle; Matthias Stelljes, University of Münster, Münster; Peter Dreger, University of Heidelberg, Heidelberg; Andreas Günther, University Hospital Schleswig Holstein Campus Kiel, Kiel; Wolfgang Bethge, University Hospital Tübingen, Tübingen; Guido Kobbe, Heinrich Heine University, Düsseldorf, Germany; Simona Iacobelli, Università Tor Vergata, Rome; Giorgio Lambertenghi Deliliers and Francesco Onida, Fondazione IRCC Ca' Granda Ospedale Maggiore Policlinico, University of Milano, Milan; Massimo Pini, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria; Stefano Guidi, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Ruzena Uddin, Guy's Hospital, London, United Kingdom; Marie Robin, Hôpital Saint Louis, Assistance Publique Hôpitaux Paris, France; Boris Afanasyev, SPB Pavlov Medical University, St Petersburg, Russia; Dominik Heim, University Hospital Basel, Basel Switzerland; Liisa Volin, Helsinki University Hospital, Helsiniki, Finland; Xavier Poiré, Cliniques Universitaires St-Luc, Brussels, Belgium; Marleen van Os, European Group of Blood and Marrow Transplantation Clinical Trials Office; Ronald Brand, Leiden University Medical Center, Leiden; and Theo de Witte, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7349DOI Listing
July 2017

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.

Cancer 2017 06 17;123(11):1965-1970. Epub 2017 Feb 17.

Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30604DOI Listing
June 2017

Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis.

Ann Hematol 2017 Jun 25;96(6):935-942. Epub 2017 Mar 25.

R.M.Gorbacheva Memorial Institute of Oncology, Hematology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-2975-0DOI Listing
June 2017

Mesenchymal Stem Cell Magnetization: Magnetic Multilayer Microcapsule Uptake, Toxicity, Impact on Functional Properties, and Perspectives for Magnetic Delivery.

Adv Healthc Mater 2016 12 18;5(24):3182-3190. Epub 2016 Nov 18.

Department of Hematology, Transfusion, and Transplantation, First I. P. Pavlov State Medical University of St. Petersburg, Lev Tolstoy str., 6/8, 197022, Saint Petersburg, Russian Federation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/adhm.201600843DOI Listing
December 2016

Intracellular redox induced drug release in cancerous and mesenchymal stem cells.

Colloids Surf B Biointerfaces 2016 Nov 23;147:450-458. Epub 2016 Aug 23.

RASA center in Tomsk, Tomsk Polytechnic University, pros. Lenina, 30, Tomsk, Russian Federation; RASA center in St.Petersburg, Peter The Great St.Petersburg Polytechnic University, St.Petersburg, Russian Federation; School of Engineering and Materials Science, Queen Mary University of London, Mile End Road, London E1 4NS, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2016.08.034DOI Listing
November 2016

Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

Biol Blood Marrow Transplant 2016 Jun 10;22(6):1037-1042. Epub 2016 Mar 10.

R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, The First Saint-Petersburg State Medical University named I.P. Pavlov, Saint-Petersburg, Russian Federation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.004DOI Listing
June 2016

Tyrosine Kinases in Cancer.

Biomark Insights 2015 2;10(Suppl 3):41-2. Epub 2015 Nov 2.

Bone Marrow Transplantation Department, Clinic of Haematology, Oncology and Tumorimmunology, School of Medicine, Charité University, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/BMI.S34403DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631159PMC
November 2015

Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Dec 10;19(12):1677-82. Epub 2013 Sep 10.

R.M. Gorbacheva Memorial Institute of Children's Hematology and Transplantation, I.P. Pavlov State Medical University, 6/8 Lev Tolstoy St, St Petersburg, Russia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.08.015DOI Listing
December 2013

Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia.

Leuk Lymphoma 2008 Oct;49(10):1916-24

Department of Hematology, Ullevaal University Hospital, and Department of Nutrition, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802339723DOI Listing
October 2008